European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow. Meulenbroek, O., O'Dwyer, S., de Jong, D., van Spijker, G., Kennelly, S., Cregg, F., Rikkert, M. O., Abdullah, L., Wallin, A., Walsh, C., & others BMJ Open, 6(7):e011584, British Medical Journal Publishing Group, 2016.
bibtex   
@article{meulenbroek2016european,
  title={European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow},
  author={Meulenbroek, Olga and O'Dwyer, Sarah and de Jong, Daan and van Spijker, Gerrita and Kennelly, Sean and Cregg, Fiona and Rikkert, Marcel Olde and Abdullah, Laila and Wallin, Anders and Walsh, Cathal and others},
  journal={BMJ Open},
  volume={6},
  number={7},
  pages={e011584},
  year={2016},
  publisher={British Medical Journal Publishing Group}
}
Downloads: 0